BFPET for Regional Myocardial Perfusion Imaging

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

May 30, 2019

Study Completion Date

September 30, 2019

Conditions
Coronary Artery Disease
Interventions
DRUG

BFPET

Sterile study drug will be delivered in individual dosage vials labeled and calibrated to approximately 2 mCi (74MBq) for the rest imaging and up to 8 mCi (296 MBq) for the stress imaging at the time of injection. The drug will be administered intravenously by bolus injection over 10 seconds into a peripheral vein to which access has been secured followed by saline flush.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Fluoropharma, Inc.

INDUSTRY